Carboplatin plus oral etoposide in the management of unresectable non-small cell lung cancer. Preliminary results of a Vanderbilt trial.

No abstract is available for this paper.

• Publication year

  1992

• Venue

  Oncology

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers
  DOI 10.1159/000227112PMID 1323813
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Phase II trial of VP16-213 in non-small cell lung cancer (NSCLC)

  2004cited by this paper
• Prolonged administration of oral etoposide in patients with relapsed or refractory small-cell lung cancer: a phase II trial.

  1990cited by this paper
• Chemotherapy for unresectable non-small cell lung cancer.

  1990cited by this paper
• Cancer statistics, 1990

  1990cited by this paper
• A randomized study comparing cisplatin or carboplatin with etoposide in patients with advanced non-small-cell lung cancer: European Organization for Research and Treatment of Cancer Protocol 07861.

  1990cited by this paper
• Overview of carboplatin: replacing, complementing, and extending the therapeutic horizons of cisplatin.

  1989cited by this paper
• Chronic daily administration of oral etoposide--a phase I trial.

  1989cited by this paper
• Combination chemotherapy versus single agents followed by combination chemotherapy in stage IV non-small-cell lung cancer: a study of the Eastern Cooperative Oncology Group.

  1989cited by this paper
• Phase II study of carboplatin in non-small cell lung cancer.

  1989cited by this paper
• Randomized Phase II Evaluation of Iproplatin (CHIP) and Carboplatin (CBDCA) in Lung Cancer: A Southeastern Cancer Study Group Trial

  1988cited by this paper
• Carboplatin or iproplatin in advanced non-small cell lung cancer: a Cancer and Leukemia Group B Study.

  1987cited by this paper
• Phase II trial of carboplatin in non-small cell lung cancer.

  1986cited by this paper
• Preclinical antitumor and toxicologic profile of carboplatin.

  1985cited by this paper
• Preclinical studies identifying carboplatin as a viable cisplatin alternative.

  1985cited by this paper
• VP-16-213 chemotherapy for advanced squamous cell carcinoma and adenocarcinoma of the lung.

  1978cited by this paper
• A clinical trial of the oral form of 4'-demethyl-epipodophyllotoxin-beta-D ethylidene glucoside (NSC 141540) VP 16-213.

  1975cited by this paper

• Chemotherapy dose--response relationships in non-small cell lung cancer and implied resistance mechanisms.

  2007cites this paper
• Prolonged oral versus high-dose intravenous etoposide in combination with carboplatin for stage IV non-small-cell lung cancer (NSCLC): a randomized trial.

  1999cites this paper
• Carboplatin-Oral Etoposide Personalised Dosing in Elderly Non-small Cell Lung Cancer Patients

  1998cites this paper
• Carboplatin-oral etoposide personalized dosing in elderly non-small cell lung cancer patients. Gruppo Oncologico Cooperativo Sud-Italia.

  1998cites this paper
• Evolving role of oral chemotherapy for the treatment of patients with neoplasms.

  1998cites this paper
• Prolonged administration of oral etoposide alone or with intravenous carboplatin in stage IV non-small cell lung cancer: a randomized trial.

  1997cites this paper
• Paclitaxel plus carboplatin in advanced non-small-cell lung cancer: a phase II trial.

  1996cites this paper
• Dose-escalation study of oral etoposide and carboplatin in patients with advanced lung cancer.

  1996cites this paper
• Carboplatin-based chemotherapy in patients undergoing hemodialysis.

  1996cites this paper
• [Carboplatin-VP16 combination in non small cell lung cancers in the aged patient. A study of the French group in pneumology (GFPC)].

  1995cites this paper
• Etoposide: twenty years later.

  1995cites this paper
• Randomized trial of hyperfractionated radiation therapy with or without concurrent chemotherapy for stage III non-small-cell lung cancer.

  1995cites this paper
• A phase II trial of carboplatin and vindesine in patients with non-small cell lung cancer. A Hellenic Cooperative Oncology Group study.

  1993cites this paper
• Novel chemotherapeutic agents in the treatment of non-small-cell lung cancer.

  1993cites this paper
• Combination chemotherapy with oral etoposide.

  1992cites this paper